We further investigated the relationship between the clinicopathological features of patients with glioma and found that the expression of WEE2-AS1 was positively correlated with WHO grade, histological type, IDH status, 1p/19q codeletion status, and EGFR status of patients with glioma. Here, IDH2 is linked to central nervous system cancer.